Amyotrophic Lateral Sclerosis Market Research
What is Amyotrophic Lateral Sclerosis (ALS)?
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the death of motor neutrons, leading to the loss of muscle control, making daily tasks quite difficult to perform. A minority of patients with ALS have a family history of the disease, with most patients having sporadic disease. ALS symptoms often begin with muscle spasms such as twitching, limb weakness, or slurred speech. ALS can eventually lead to further effects in muscles that control movement, speech, eating, and even breathing. Currently, there is no cure for this debilitating disease. However, the FDA has approved multiple therapies to slow the loss of physical function/disease progression.
Spherix Global Insights – Neurology – Amyotrophic lateral sclerosis (ALS)
Spherix’s Neurology team covers the amyotrophic lateral sclerosis (ALS) market in our Market Dynamix™ and Launch Dynamix™ services. Spherix’s has the following studies publishing this year covering ALS:
- Market Dynamix™: Amyotrophic Lateral Sclerosis (US)
- Launch Dynamix™: Relyvrio (Amylyx) in Amyotrophic Lateral Sclerosis (US)
*Pending approval and launch
Spherix’s Launch Dynamix™ for ALS consists of quarterly deep dives during the first eighteen months of commercial availability probing launch KPIs, promotional activity, drivers and barriers to uptake, and patient types gravitating to the launch brand.
Spherix’s Launch Dynamix™ for NMOSD consists of quarterly deep dives during the first eighteen months of commercial availability probing launch KPIs, promotional activity, drivers and barriers to uptake, and patient types gravitating to the launch brand.
Follow Spherix Neurology on Social Media
Follow us for neurology industry news, insights & analysis:
Twitter: https://twitter.com/SpherixNeuro
LinkedIn: https://www.linkedin.com/company/spherix-global-insights/
For Guests & Current Clients
For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:
